Cargando…

1741. Invasive Fungal Infections in Patients with Multiple Myeloma in the Era of Novel Therapies

BACKGROUND: Rapid advances in multiple myeloma (MM) therapy have led to improved survival, yet the impact of novel agents on the risk of invasive fungal infection (IFI) is largely unknown. We aim to describe the epidemiology of IFIs in MM patients in the current era of chemotherapy. METHODS: We perf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baneman, Emily, Chari, Ajai, Rana, Meenakshi, Dunn, Dallas, Sullivan, Timothy, Taimur, Sarah, Sanchez, Larysa, Jacobs, Samantha E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809237/ http://dx.doi.org/10.1093/ofid/ofz360.1604

Ejemplares similares

583. Successful prevention of Strongyloides reactivation in liver transplant recipients with individualized screening and treatment: 10 year experience at a large transplant center in New York City
por: Rahman, Farah, et al.
Publicado: (2020)

2101. CMV Infections in Multiple Myeloma Patients
por: Ilyas, Sahrish, et al.
Publicado: (2022)

Book Review: The Royal Devon and Exeter Hospital 1741–2006
por: Dale, Pamela
Publicado: (2010)

1741 Emergence of Shigellosis in Males ≥13 Years — Philadelphia, 2008–2013
por: Finn, Lauren, et al.
Publicado: (2014)

1741P Triage procedures for COVID-19 in an Italian cancer centre
por: Targato, G., et al.
Publicado: (2020)

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2021)

Dr. John Mitchell’s Account of the Yellow Fever in Virginia in 1741-42, Written in 1748
Publicado: (1934)

Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2010)

Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
por: Theodoropoulos, Nicholas, et al.
Publicado: (2020)

Selinexor in relapsed/refractory multiple myeloma
por: Richter, Joshua, et al.
Publicado: (2020)

The SEB1741 Aptamer Is an Efficient Tool for Blocking CD4+ T Cell Activation Induced by Staphylococcal Enterotoxin B
por: Chavez-Galan, Leslie, et al.
Publicado: (2023)

Relapsed Babesia microti Infection Following Allogeneic Hematopoietic Cell Transplantation in a Patient With B-cell Acute Lymphoblastic Leukemia: Case Report and Review of the Literature
por: Rosenblatt, Joshua, et al.
Publicado: (2021)

PB1741: DIFFERENTIAL DIAGNOSIS OF T-LYMPHOBLASTIC LYMPHOMA/LEUKEMIA AND THYMOMA USING FLOW CYTOMETRY IN PLEURAL FLUID
por: Bae, Goeun, et al.
Publicado: (2023)

P1741: EXAMINING THE BURDEN OF ILLNESS ASSOCIATED WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA FROM THE PATIENT’S PERSPECTIVE
por: Knoth, R. L., et al.
Publicado: (2022)

The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution
por: Bonomo, Lauren, et al.
Publicado: (2016)

Genetic Diversity and Population Parameters of Sea Otters, Enhydra lutris, before Fur Trade Extirpation from 1741–1911
por: Larson, Shawn, et al.
Publicado: (2012)

B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
por: Shah, Nina, et al.
Publicado: (2020)

Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach
por: Laganà, Alessandro, et al.
Publicado: (2018)

Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 2013;36:1735–1741
Publicado: (2013)

Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study
por: Chari, Ajai, et al.
Publicado: (2016)

Elotuzumab for the treatment of multiple myeloma
por: Wang, Yucai, et al.
Publicado: (2016)

La généalogie de l'histopathologie. Une révision déchirante. Philippe Pinel, lecteur discret de J.-C. Smyth (1741–1821)
por: Pickstone, J. V.
Publicado: (1984)

Binary Blend All‐Polymer Solar Cells with a Record Efficiency of 17.41% Enabled by Programmed Fluorination Both on Donor and Acceptor Blocks
por: Zhou, Dehong, et al.
Publicado: (2022)

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma
por: Hannaford, Alisse, et al.
Publicado: (2017)

Invasive Fungal Rhinosinusitis in the Era of COVID-19: Is It an Emerging Association?
por: Chatzisouleiman, Ipek, et al.
Publicado: (2022)

2106. Evaluation of Isavuconazole for the Prophylaxis and Treatment of Invasive Fungal Infections at a Large Academic Medical Center
por: Vu, Christine, et al.
Publicado: (2019)

Patient‐Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
por: Chari, Ajai, et al.
Publicado: (2019)

Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma
por: Parrondo, Ricardo D, et al.
Publicado: (2019)

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
por: Mouhieddine, Tarek H., et al.
Publicado: (2022)

Fungal Infections and Myeloma: Supports
por: Yavaşoğlu, İrfan
Publicado: (2023)

Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs
por: Facchinelli, Davide, et al.
Publicado: (2018)

Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
por: Ailawadhi, Sikander, et al.
Publicado: (2022)

NS-64: Lessons learned: patient management and outcomes of Multiple Myeloma patients during the COVID-19 pandemic in New York City
por: Catamero, Donna, et al.
Publicado: (2021)

CT Imaging Features in Acute Invasive Fungal Rhinosinusitis- Recalling the Oblivion in the COVID Era
por: Khullar, Tamanna, et al.
Publicado: (2022)

P492 Invasive fungal infection during COVID era at tertiary care hospital
por: Seema, Kumari, et al.
Publicado: (2022)

Case series discussion of cardiac and vascular events following carfilzomib treatment: possible mechanism, screening, and monitoring
por: Chari, Ajai, et al.
Publicado: (2014)

Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2016)

B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies
por: Sanchez, Larysa, et al.
Publicado: (2021)

Fungal biology in the post-genomic era
por: Scazzocchio, Claudio
Publicado: (2014)

MALDI-TOF MS in Adult Inpatients with Bloodstream Infections: Pre- and Post-intervention Study
por: Khan, Salman, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ov02dsjfkbcj5t85dm4iml294l